Ballantyne Charles Evan

Avg. Two Year Performance

(3%) Avg. Purchase Return
(2%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return1%2%(18%)(6%)(3%)
Purchase Success Rate2 of 52 of 52 of 53 of 51 of 5
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

CFO:

Holdings: 14.65K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

EVP, CFO:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

CHIEF FINANCIAL OFFICER:

Holdings: 10.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Financial Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--